 |
|
Photo copyright Martin Wall
|
Common names: Gugulipid, Gum guggulu
Botanical name: Commiphora mukul
Parts used and where grown: The mukul myrrh (Commiphora
mukul) tree is a small, thorny plant distributed throughout India. Guggul and gum guggulu
are the names given to a yellowish resin produced by the stem of the plant. This resin has
been used historically and is also the source of modern extracts of guggul.
Guggul has been used in
connection with the following conditions (refer to the individual
health concern for complete information):
Historical or traditional use (may or may not
be supported by scientific studies): The classical treatise on Ayurvedic medicine, Sushrita Samhita, describes
the use of guggul for a wide variety of conditions, including rheumatism and obesity. One of its primary indications was a condition known
as medoroga. This ancient diagnosis is similar to the modern description of atherosclerosis. Standardized guggul extracts are
approved in India for lowering elevated serum
cholesterol and triglyceride levels.
Active constituents: Guggul contains resin, volatile oils, and
gum. The extract isolates ketonic steroid compounds known as guggulsterones. These compounds
have been shown to provide the cholesterol- and triglyceride-lowering actions noted for
guggul.1 Guggul significantly lowers serum triglycerides and cholesterol as well as LDL and VLDL cholesterols (the
“bad” cholesterols).2 At the same time, it raises levels of HDL
cholesterol (the “good” cholesterol). As
antioxidants, guggulsterones keep LDL cholesterol from oxidizing, an action which protects
against atherosclerosis.3 Guggul has
also been shown to reduce the stickiness of platelets—another effect that lowers the
risk of coronary artery disease.4 One double-blind trial found guggul extract
similar to the drug clofibrate for lowering cholesterol
levels.5 Other clinical trials in India (using 1,500 mg of extract per day) have
confirmed guggul extracts improve lipid levels in humans.6
A combination of guggul, phosphate salts, hydroxycitrate, and tyrosine coupled with exercise has been shown in a double-blind
trial to improve mood with a slight tendency to improve weight loss in overweight
adults.7
One small clinical trial found that guggul (Commiphora mukul) compared favorably
to tetracycline in the treatment of cystic
acne.8 The amount of guggul extract taken in the trial was 500 mg twice per
day.
How much is usually taken? Daily recommendations for the
purified guggul extract are typically based on the amount of guggulsterones in the
extract.9 A common intake of guggulsterones is 25 mg three times per day. Most
extracts contain 2.5–5% guggulsterones and can be taken daily for 12 to 24 weeks for
lowering high cholesterol and/or triglycerides.
Are there any side effects or interactions? Early studies with
the crude oleoresin reported numerous side effects, including diarrhea,
anorexia, abdominal pain, and skin rash. Modern extracts are more purified, and fewer side
effects (e.g., mild abdominal discomfort) have been reported with long-term use. Guggul should
be used with caution by people with liver disease and in cases of inflammatory bowel disease and diarrhea. A physician should be consulted before treating
elevated cholesterol and triglycerides.
At the time of writing, there were no well-known drug interactions
with guggul.
References:
1. Satyavati GV. Gum guggul (Commiphora mukul)—The success
of an ancient insight leading to a modern discovery. Indian J Med
1988;87:327–35.
2. Nityanand S, Kapoor NK. Hypocholesterolemic effect of Commiphora
mukul resin (Guggal). Indian J Exp Biol 1971;9:367–77.
3. Singh K, Chander R, Kapoor NK. Guggulsterone, a potent hypolipidaemic,
prevents oxidation of low density lipoprotein. Phytother Res 1997;11:291–4.
4. Mester L, Mester M, Nityanand S. Inhibition of platelet aggregation by
guggulu steroids. Planta Med 1979;37:367–9.
5. Malhotra SC, Ahuja MMS, Sundarum KR. Long-term clinical studies on the
hypolipidemic effect of Commiphora mukul (guggul) and clofibrate. Ind J Med
Res 1977;65:390–5.
6. Nityanand S, Srivastava JS, Asthana OP. Clinical trials with
gugulipid—a new hypolipidemic agent. J Assoc Phys India
1989;37:323–8.
7. Antonio J, Colker CM, Torina GC, et al. Effects of a standardized
guggulsterone phosphate supplement on body composition in overweight adults: A pilot study.
Curr Ther Res 1999;60:220–7.
8. Thappa DM, Dogra J. Nodulocystic acne: oral gugulipid versus
tetracycline. J Dermatol 1994;21:729–31.
9. Brown D, Austin S. Hyperlipidemia and Prevention of Coronary
Artery Disease. Seattle, WA: NPRC, 1997, 4–6.
Copyright © 2002 Healthnotes, Inc. All rights reserved.
www.healthnotes.com
Learn more about Healthnotes, the company.
Learn more about the authors of Healthnotes.
The information presented in Healthnotes is for informational
purposes only. It is based on scientific studies (human, animal, or in vitro),
clinical experience, or traditional usage as cited in each article. The results reported may
not necessarily occur in all individuals. For many of the conditions discussed, treatment with
prescription or over-the-counter medication is also available. Consult your doctor,
practitioner, and/or pharmacist for any health problem and before using any supplements or
before making any changes in prescribed medications. Information expires December 2003.
|